| Patient Engagement Manager |
Bratislava |
Slovaquie |
International |
Universal Hierarchy Node |
Communications & Public Affairs |
28 mai 2025 |
| Communications & Patient Advocacy Manager |
Selangor |
Malaisie |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
28 mai 2025 |
| Associate Director, Rare Hematology, US Patient Advocacy |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
27 mai 2025 |
| Director, Corporate Leadership, US Patient Advocacy |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
27 mai 2025 |
| Associate Director, Oncology, US Patient Advocacy |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
27 mai 2025 |
| Community Health Lead, Mexico |
INSURGENTES |
Mexique |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
27 mai 2025 |
| Brand Communications & Patient Advocacy Manager (f/m/d) |
Vienna |
Autriche |
International |
CTS |
Communications & Public Affairs |
22 mai 2025 |
| Director, CEO Strategic Affairs |
Basel (City) |
Suisse |
Corporate |
Corporate |
Communications & Public Affairs |
22 mai 2025 |
| Head of Public Affairs, Saudi Arabia |
Riyadh |
Royaume d'Arabie Saoudite |
People & Organization |
Universal Hierarchy Node |
Communications & Public Affairs |
19 mai 2025 |
| Country Communications & Patient Advocacy Head, Korea |
Seoul |
République de Corée |
International |
Sandoz |
Communications & Public Affairs |
18 mai 2025 |
| Country Communications & Patient Advocacy Head |
Bangkok |
Thaïlande |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
16 mai 2025 |
| Associate Director, Communications (R&D Portfolio & Engagement) |
Cambridge (Massachusetts) |
Etats-Unis |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
15 mai 2025 |
| TA Communications & Patient Advocacy Manager |
Amsterdam |
Pays-Bas |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
14 mai 2025 |
| Director of Partnership Communications |
East Hanover |
Etats-Unis |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
14 mai 2025 |
| ED & Head, Novartis Patient Assistance Foundation |
East Hanover |
Etats-Unis |
US |
Universal Hierarchy Node |
Communications & Public Affairs |
13 mai 2025 |
| Public Affairs Manager (Istanbul/Ankara) |
Istanbul Ataşehir |
Turquie |
International |
Innovative Medicines |
Communications & Public Affairs |
13 mai 2025 |
| Manager, Patient Engagement |
Shanghai (Shanghai) |
Chine |
Corporate Affairs |
CTS |
Communications & Public Affairs |
13 mai 2025 |
| TA Communications and Patient Advocacy Lead |
Istanbul Ataşehir |
Turquie |
International |
CTS |
Communications & Public Affairs |
09 mai 2025 |
| Director, Communications (Finance) |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
09 mai 2025 |
| PSP Specialist (Fixed Term contractor) |
Seoul |
République de Corée |
International |
Innovative Medicines |
Communications & Public Affairs |
08 mai 2025 |
| Manager, Public Affairs & Policy |
INSURGENTES |
Mexique |
International |
Innovative Medicines |
Communications & Public Affairs |
08 mai 2025 |
| Director Public Affairs (m/f/d) / Direktor javnih zadev (m/ž/d) |
Ljubljana |
République de Slovénie |
People & Organization |
Corporate |
Communications & Public Affairs |
05 mai 2025 |
| Director, Strategy & Operations |
East Hanover |
Etats-Unis |
Corporate Affairs |
CTS |
Communications & Public Affairs |
30 avril 2025 |
| Head Public Affairs (f/m/d) |
Vienna |
Autriche |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
29 avril 2025 |
| Manager javnih zadev (m/ž/d) / Public Affairs Manager (m/f/d) |
Ljubljana |
République de Slovénie |
People & Organization |
Corporate |
Communications & Public Affairs |
24 avril 2025 |
| Manager, Product Brand Comms |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
22 avril 2025 |
| Associate Director, Executive, External Communications & Engagement |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Universal Hierarchy Node |
Communications & Public Affairs |
19 avril 2025 |
| Director of Corporate Reputation |
East Hanover |
Etats-Unis |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
17 avril 2025 |
| Director, Public Affairs (Policy) |
Beijing (Beijing) |
Chine |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
10 mars 2025 |
| Director, Public Affairs (North Region) |
Beijing (Beijing) |
Chine |
Corporate Affairs |
Innovative Medicines |
Communications & Public Affairs |
10 mars 2025 |
| Director, Corporate Communications, China |
Shanghai (Shanghai) |
Chine |
Corporate Affairs |
CTS |
Communications & Public Affairs |
04 mars 2025 |
| Manager, TA Patient Advocacy |
Shanghai (Shanghai) |
Chine |
Corporate Affairs |
CTS |
Communications & Public Affairs |
04 mars 2025 |
| Manager, TA Communications |
Shanghai (Shanghai) |
Chine |
Corporate Affairs |
CTS |
Communications & Public Affairs |
04 mars 2025 |
| Country Head, Public Affairs |
Vietnam |
République socialiste du Viêt Nam |
People & Organization |
Universal Hierarchy Node |
Communications & Public Affairs |
23 février 2025 |
| Director, Portfolio Advocacy APMA |
Mapletree Business City (MBC) |
Singapour |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
10 février 2025 |
| Executive Director, Public Affairs Asia Aspiring |
Mapletree Business City (MBC) |
Singapour |
People & Organization |
Corporate |
Communications & Public Affairs |
10 février 2025 |
| Sr Manager, Executive Communications |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
23 janvier 2025 |
| Sr Manager, Growth Strategy and Policy Communications |
Toranomon (NPKK Head Office) |
Japon |
Corporate Affairs |
Universal Hierarchy Node |
Communications & Public Affairs |
23 janvier 2025 |